Kymera Therapeutics: The More This Biotech Spends, The Higher Its Valuation Rises
Source: SeekingAlpha
2026-02-20 17:10:51 ET
Investment Overview
Kymera Therapeutics ( KYMR ) is a Watertown, Massachusetts based biotech I have been covering since I shared a note with Seeking Alpha back in January 2021, issuing a Buy rating....
Read the full article on Seeking Alpha
For further details see:
Kymera Therapeutics: The More This Biotech Spends, The Higher Its Valuation Rises
Kymera Therapeutics Inc.
NASDAQ: KYMR
KYMR Trading
-1.13% G/L:
$81.49 Last:
128,340 Volume:
$81.55 Open:
KYMR Latest News
February 26, 2026 07:00:00 am
Kymera Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
February 24, 2026 07:00:00 am
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
KYMR Stock Data
$6,259,529,627
60,213,376
0.01%
74
N/A
Biotechnology & Life Sciences
Healthcare
US
Watertown
